Female Genital Mutilation and Cutting and Obstetric Outcomes.


Journal

Obstetrics and gynecology
ISSN: 1873-233X
Titre abrégé: Obstet Gynecol
Pays: United States
ID NLM: 0401101

Informations de publication

Date de publication:
01 07 2022
Historique:
received: 23 01 2022
accepted: 31 03 2022
entrez: 18 7 2022
pubmed: 19 7 2022
medline: 22 7 2022
Statut: ppublish

Résumé

The aim of this prospective study was to investigate the association of type III female genital mutilation/cutting (FGM/C) and de-infibulation with immediate maternal and neonatal outcomes. Women with type III FGM/C were compared with women with type I or II FGM/C or no FGM/C. Only uncomplicated singleton, full-term pregnancies with the fetus in vertex presentation were included. There was a greater frequency of postpartum hemorrhage and the use of mediolateral episiotomy in women with type III FGM/C. Mediolateral episiotomy was associated with a reduced rate of any spontaneous perineal laceration as well as third-degree and fourth-degree lacerations in women with type III FGM/C who underwent de-infibulation.

Identifiants

pubmed: 35849461
doi: 10.1097/AOG.0000000000004830
pii: 00006250-202207000-00014
doi:

Types de publication

Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

87-90

Informations de copyright

Copyright © 2022 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Financial Disclosure The authors did not report any potential conflicts of interest.

Références

Elduma AH. Female genital mutilation in Sudan. Maced J Med Sci 2018;6:430–4. doi: 10.3889/oamjms.2018.099
doi: 10.3889/oamjms.2018.099
Lurie JM, Weidman A, Huynh S, Delgado D, Easthausen I, Kaur G. Painful gynecologic and obstetric complications of female genital mutilation/cutting: a systematic review and meta-analysis. PloS One 2021. doi: 10.1371/journal.pmed.1003088
doi: 10.1371/journal.pmed.1003088
Sylla F, Moreau C, Andro A. A systematic review and meta-analysis of the consequences of female genital mutilation on maternal and perinatal health outcomes in Europe and African countries. BMJ Glob Health 2020;5:e003307. doi: 10.1136/bmjgh-2020-003307
doi: 10.1136/bmjgh-2020-003307
Berg RC, Odgaard-Jensen J, Fretheim A, Underland V, Vist G. An updated systematic review and meta-analysis of the obstetric consequences of female genital mutilation/cutting. Obstet Gynecol Int 2014;2014:542859. doi: 10.1155/2014/542859
doi: 10.1155/2014/542859
Abdulcadir J, Rodriguez MI, Say L. Research gaps in the care of women with female genital mutilation: an analysis. BJOG 2015;122:294–303. doi: 10.1111/1471-0528.13217
doi: 10.1111/1471-0528.13217
Indraccolo U, Indraccolo SR, Greco P, Fedeli P. Correlations between the proportion of type III female genital mutilations in the series and adverse obstetric outcomes: a short meta-analysis. J Matern Fetal Neonatal Med 2020;33:880–2. doi: 10.1080/14767058.2018.1503246
doi: 10.1080/14767058.2018.1503246
Banks E, Meirik O, Farley T, Akande O, Bathija H, Ali M. Female genital mutilation and obstetric outcome: WHO collaborative prospective study in six African countries. Lancet 2006;367:1835–41. doi: 10.1016/S0140-6736(06)68805-3
doi: 10.1016/S0140-6736(06)68805-3
Okusanya BO, Oduwole O, Nwachuku N, Meremikwu MM. Deinfibulation for preventing or treating complications in women living with type III female genital mutilation: a systematic review and meta-analysis. Int J Gynecol Obstet 2017;136:13–20. doi: 10.1002/ijgo.12056
doi: 10.1002/ijgo.12056
Esu E, Udo A, Okusanya BO, Agamse D, Meremikwu MM. Antepartum or intrapartum deinfibulation for childbirth in women with type III female genital mutilation: a systematic review and meta-analysis. Int J Gynaecol Obstet 2017;136:21–9. doi: 10.1002/ijgo.12055
doi: 10.1002/ijgo.12055
Royal College of Obstetricians and Gynaecologists. Female genital mutilation and its management. Green-top guideline No. 53. Accessed November 15, 2021. https://www.rcog.org.uk/en/guidelines-research-services/guidelines/gtg53/
Perron L, Senikas V, Burnett M, Davis V; Social Sexual Issues Committee; Ethics Committee. Female genital cutting. J Obstet Gynaecol Can 2013;35:1028–45. doi: 10.1016/S1701-2163(15)30792-1
doi: 10.1016/S1701-2163(15)30792-1
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007;370:1453–7. doi: 10.1016/S0140-6736(07)61602-X
doi: 10.1016/S0140-6736(07)61602-X
World Health Organization. Female genital mutilation. Accessed November 15, 2021. https://www.who.int/news-room/fact-sheets/detail/female-genital-mutilation
Berg RC, Underland V, Odgaard-Jensen J, Fretheim A, Vist GE. Effects of female genital cutting on physical health outcomes: a systematic review and meta-analysis. BMJ Open 2014;4:e006316. doi: 10.1136/bmjopen-2014-006316
doi: 10.1136/bmjopen-2014-006316

Auteurs

Giulia Bonavina (G)

Port Sudan Maternity Teaching Hospital, Port Sudan, Red Sea State, Sudan; and the Department of Obstetrics and Gynecology and the Division of Urogynecology, IRCCS San Raffaele Scientific Institute, University Vita and Salute, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH